These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17533006)

  • 1. Cytokines in glomerulonephritis.
    Tipping PG; Holdsworth SR
    Semin Nephrol; 2007 May; 27(3):275-85. PubMed ID: 17533006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerulonephritis, Th1 and Th2: what's new?
    Tipping PG; Kitching AR
    Clin Exp Immunol; 2005 Nov; 142(2):207-15. PubMed ID: 16232206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells in crescentic glomerulonephritis.
    Tipping PG; Holdsworth SR
    J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A; Gómez-Chiarri M; Alonso J; Bustos C; Gómez-Guerrero C; López-Armada MJ; Gómez-Garre D; Palacios I; Ruíz-Ortega M; Gutierrez S
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
    Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
    Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of renal inflammation: therapeutic strategies.
    Karkar A
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):1-19. PubMed ID: 18087117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of experimental pathology to the understanding of human immune glomerulonephritis].
    Ronco P; Verroust P; Chatelet F
    Rev Prat; 1991 Nov; 41(24):2411-8. PubMed ID: 1803451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis.
    Kluger MA; Ostmann A; Luig M; Meyer MC; Goerke B; Paust HJ; Meyer-Schwesinger C; Stahl RA; Panzer U; Tiegs G; Steinmetz OM
    Eur J Immunol; 2014 Mar; 44(3):683-93. PubMed ID: 24227595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK; Kitching AR; Jones LK; Holdsworth SR
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of intrinsic renal cells to crescentic glomerulonephritis.
    Tipping PG; Timoshanko J
    Nephron Exp Nephrol; 2005; 101(4):e173-8. PubMed ID: 16155400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis.
    Holdsworth SR; Kitching AR; Tipping PG
    Kidney Int; 1999 Apr; 55(4):1198-216. PubMed ID: 10200982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of cytokines for development of protective immunity and rational design of vaccines.
    Chabalgoity JA; Baz A; Rial A; Grille S
    Cytokine Growth Factor Rev; 2007; 18(1-2):195-207. PubMed ID: 17347024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines: Names and Numbers You Should Care About.
    Holdsworth SR; Gan PY
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2243-54. PubMed ID: 25941193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immune response and hepatic inflammation.
    Szabo G; Mandrekar P; Dolganiuc A
    Semin Liver Dis; 2007 Nov; 27(4):339-50. PubMed ID: 17979071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of T helper and T regulatory cell responses at birth.
    Schaub B; Liu J; Schleich I; Höppler S; Sattler C; von Mutius E
    Allergy; 2008 Nov; 63(11):1438-47. PubMed ID: 18925880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokines in inflammatory glomerular injury.
    Lakkis FG; Coêlho SN
    Miner Electrolyte Metab; 1995; 21(4-5):250-61. PubMed ID: 7565474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells in glomerulonephritis.
    Tipping PG; Holdsworth SR
    Springer Semin Immunopathol; 2003 May; 24(4):377-93. PubMed ID: 12778334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.